Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Dietz J (2020) Recommendations for prioritization, treatment and triage of breast cancer patients during the COVID-19 pandemic: executive summary. Retrieved 24 Mar 2020. https://www.nccn.org/covid-19/pdf/The_COVID-19_Pandemic_Breast_Cancer_Consortium_Recommendations_EXECUTIVE_SUMMARY.pdf. Accessed 15 Apr 2020.
2. Bartlett DL, Howe JR, Chang G et al (2020) Management of cancer surgery cases during the COVID-19 pandemic: considerations. Ann Surg Oncol 27(6):1717–1720
3. Chiba A, Hoskin TL, Heins CN, Hunt KK, Habermann EB, Boughey JC (2017) Trends in neoadjuvant endocrine therapy use and impact on rates of breast conservation in hormone receptor-positive breast cancer: a national cancer data base study. Ann Surg Oncol 24(2):418–424
4. Weiss A, King TA, Mittendorf EA (2020) The landmark series: neoadjuvant endocrine therapy for breast cancer. Ann Surg Oncol 27(9):3393–3401
5. Dowsett M, Ellis MJ, Dixon JM et al (2020) Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic. NPJ Breast Cancer 6:21
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献